argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025
argenx (Euronext & Nasdaq: ARGX), a global immunology company focused on severe autoimmune diseases, has announced it will host a conference call and audio webcast on Thursday, February 27, 2025, at 2:30 PM CET (8:30 AM ET) to discuss its full year 2024 financial results and provide a fourth quarter business update.
The webcast will be accessible through the Investors section of the argenx website, with a replay available for approximately one year. The company has provided international dial-in numbers for Belgium, France, Netherlands, United Kingdom, United States, Japan, and Switzerland, with access code 3810049 for participants to join the call.
argenx (Euronext e Nasdaq: ARGX), un'azienda globale di immunologia focalizzata sulle gravi malattie autoimmuni, ha annunciato che ospiterà una conference call e un audio webcast giovedì 27 febbraio 2025, alle 14:30 CET (8:30 AM ET) per discutere i risultati finanziari dell'intero anno 2024 e fornire un aggiornamento sulle attività del quarto trimestre.
Il webcast sarà accessibile attraverso la sezione Investitori del sito web di argenx, con una registrazione disponibile per circa un anno. L'azienda ha fornito numeri di accesso internazionali per Belgio, Francia, Paesi Bassi, Regno Unito, Stati Uniti, Giappone e Svizzera, con codice di accesso 3810049 per i partecipanti che desiderano unirsi alla chiamata.
argenx (Euronext y Nasdaq: ARGX), una empresa global de inmunología centrada en enfermedades autoinmunes severas, ha anunciado que llevará a cabo una conferencia telefónica y un audio webcast el jueves 27 de febrero de 2025, a las 2:30 PM CET (8:30 AM ET) para discutir sus resultados financieros del año completo 2024 y proporcionar una actualización sobre el negocio del cuarto trimestre.
El webcast será accesible a través de la sección de Inversores del sitio web de argenx, con una repetición disponible por aproximadamente un año. La empresa ha proporcionado números de acceso internacionales para Bélgica, Francia, Países Bajos, Reino Unido, Estados Unidos, Japón y Suiza, con el código de acceso 3810049 para que los participantes se unan a la llamada.
argenx (Euronext 및 Nasdaq: ARGX)는 중증 자가면역 질환에 집중하는 글로벌 면역학 회사로, 2025년 2월 27일 목요일 오후 2시 30분 CET (오전 8시 30분 ET)에 컨퍼런스 콜 및 오디오 웹캐스트를 개최하여 2024년 전체 연도 재무 결과를 논의하고 4분기 비즈니스 업데이트를 제공할 것이라고 발표했습니다.
웹캐스트는 argenx 웹사이트의 투자자 섹션을 통해 접근 가능하며, 약 1년 동안 재생 가능합니다. 회사는 벨기에, 프랑스, 네덜란드, 영국, 미국, 일본 및 스위스에 대한 국제 전화 접속 번호를 제공했으며, 참가자가 전화를 연결할 수 있도록 3810049 접속 코드를 제공합니다.
argenx (Euronext et Nasdaq : ARGX), une entreprise mondiale d'immunologie axée sur les maladies auto-immunes sévères, a annoncé qu'elle tiendrait une conférence téléphonique et un webcast audio le jeudi 27 février 2025, à 14h30 CET (8h30 ET) pour discuter de ses résultats financiers de l'année complète 2024 et fournir une mise à jour sur les activités du quatrième trimestre.
Le webcast sera accessible via la section Investisseurs du site web d'argenx, avec un replay disponible pendant environ un an. L'entreprise a fourni des numéros d'appel internationaux pour la Belgique, la France, les Pays-Bas, le Royaume-Uni, les États-Unis, le Japon et la Suisse, avec le code d'accès 3810049 pour que les participants puissent rejoindre l'appel.
argenx (Euronext und Nasdaq: ARGX), ein globales Immunologieunternehmen, das sich auf schwere Autoimmunerkrankungen konzentriert, hat angekündigt, dass es am Donnerstag, den 27. Februar 2025, um 14:30 Uhr CET (8:30 Uhr ET) eine Telefonkonferenz und ein Audio-Webcast veranstalten wird, um seine finanziellen Ergebnisse für das gesamte Jahr 2024 zu besprechen und ein Update zum Geschäft des vierten Quartals zu geben.
Der Webcast wird über den Bereich Investoren der argenx-Website zugänglich sein, mit einer Wiederholung, die etwa ein Jahr verfügbar sein wird. Das Unternehmen hat internationale Einwahlnummern für Belgien, Frankreich, die Niederlande, das Vereinigte Königreich, die Vereinigten Staaten, Japan und die Schweiz bereitgestellt, mit dem Zugangscode 3810049, um den Teilnehmern den Zugang zur Konferenz zu ermöglichen.
- None.
- None.
February 20, 2025
Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, February 27, 2025 at 2:30 PM CET (8:30 AM ET) to discuss its full year 2024 financial results and provide a fourth quarter business update.
A webcast of the live call may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately one year following the presentation.
Dial-in numbers:
Belgium 32 800 50 201
France 33 800 943355
Netherlands 31 20 795 1090
United Kingdom 44 800 358 0970
United States 1 800 715 9871
Japan 81 3 4578 9081
Switzerland 41 43 210 11 32
Use the access code 3810049 to join the call. Please dial in 15 minutes prior to the live call.
About argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker, globally in the U.S., Japan, Israel, the EU, the UK, China and Canada. The Company is evaluating efgartigimod in multiple serious autoimmune diseases and advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit www.argenx.com and follow us on LinkedIn, X (formerly known as Twitter), and Instagram.
Media:
Ben Petok
bpetok@argenx.com
Investors:
Alexandra Roy (US)
aroy@argenx.com
Lynn Elton (EU)
lelton@argenx.com
FAQ
When will argenx (ARGX) report its full year 2024 financial results?
How can investors access the argenx (ARGX) Q4 2024 earnings call?
How long will the argenx (ARGX) Q4 2024 earnings webcast replay be available?
What topics will be covered in the argenx (ARGX) February 27, 2025 conference call?
